Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
As CEO, my primary directives are patient safety, protecting the long-term viability of the company, and strict adherence to the law. First, I must address a critical flaw in the premise: My internal legal team’s advice that "formal regulatory reporting would take 6 months" is dangerously incorrect and potentially…Read the full answer